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Executive Summary
•	 South	Carolina’s	life	science	industry	has	been	one	of	the	fastest	growing	sectors	over	the	past	decade	and	has	
been	a	major	contributor	to	the	state’s	current	economic	expansion.	Since	2005,	annual	employment	growth	within	
the	life	science	industry	has	averaged	approximately	1.7	percent,	which	is	more	than	twice	that	of	the	state	as	a	
whole	over	the	same	time	period	(0.8%).
•	 The	life	science	industry	in	South	Carolina	currently	consists	of	approximately	15,012	employees	across	402	firms.	
Employment	is	most	concentrated	within	firms	specializing	in	bioscience-related	distribution	and	medical	devices	
&	equipment.
•	 The	 life	 science	 industry	 supports	 a	 significant	 demand	 for	 high-wage,	 high-skill	 jobs	 in	 various	 STEM	 fields	
(science,	engineering,	technology,	mathematics,	and	related	occupations).	Specifically,	the	average	direct	job	in	
the	life	science	industry	in	South	Carolina	pays	an	annual	total	compensation	of	$78,658,	which	is	approximately	
95	percent	higher	than	the	average	annual	compensation	in	South	Carolina	across	all	jobs	($40,293).
•	 Because	of	the	high	degree	of	innovation	occurring	through	various	research	and	testing	activities,	the	life	science	
industry	directly	supports	South	Carolina’s	knowledge	economy.	The	knowledge	economy	is	defined	as	consisting	
of	any	sector	that	regularly	creates	and	successfully	commercializes	new	ideas.	Because	of	its	contributions	to	
the	 knowledge	economy,	 the	 life	 science	 industry	 generates	 significant	 productivity	 gains	 for	 South	Carolina.	
Enhancing	growth	within	industries	that	boost	productivity	is	critical	for	the	long-run	economic	health	of	the	state.
•	 The	annual	economic	impact	of	the	life	science	industry	on	the	state	of	South	Carolina	totals	approximately	$11.4	
billion	in	total	economic	output.	This	figure	reflects	the	dollar	value	of	all	goods	and	services	that	can	be	attributed	
(either	directly	or	indirectly)	to	life	science-related	firms	in	South	Carolina.	This	$11.4	billion	in	economic	output	is	
associated	with	43,467	total	jobs	and	over	$2.5	billion	in	labor	income.
•	 The	 total	economic	 impact	 resulting	 from	the	 life	science	 industry	 is	associated	with	an	employment	multiplier	
of	2.9.	This	implies	that	for	every	10	jobs	that	are	created	within	the	life	science	industry	in	South	Carolina,	an	
additional	19	jobs	are	created	elsewhere	in	the	state.		
•	 The	 volume	 of	 ongoing	 research	 and	 the	 number	 of	 new	 patents	 issued	 are	 both	measures	 of	 the	 status	 of	
innovation-related	 life	 science	activities	 in	 the	pipeline	 that	will	 contribute	 to	 the	 future	growth	of	 the	 industry.	
Both	indicators	in	South	Carolina	have	shown	an	overall	positive	rate	of	growth	in	recent	years.	South	Carolina	
venture	 capital	 investment	 in	 the	 life	 science	 industry	 is	 currently	 targeted	 towards	 the	 categories	 of	 Drugs,	
Pharmaceuticals,	 Medical	 Devices,	 and	 Equipment.	 These	 categories	 also	 represent	 the	 majority	 of	 the	 life	
science	industry	in	South	Carolina	that	is	directly	tied	to	innovation.
•	 In	order	to	assess	the	perceived	strengths	and	weaknesses	of	the	life	science	industry	from	the	firm	perspective,	a	
series	of	firm-level	interviews	of	life	science	companies	in	South	Carolina	were	conducted.		The	primary	results	of	
these	interviews	indicate	that	while	firms	anticipate	high	market	demand	and	have	a	favorable	view	of	the	overall	
business	climate	in	South	Carolina,	they	also	consistently	note	that	there	is	a	shortage	of	high-skilled	workers	in	
the	state.	Addressing	this	need	has	the	potential	to	improve	the	state’s	overall	competitiveness	and	to	enhance	
the	long-run	growth	potential	of	the	life	science	industry.		
1 Source: U.S. Bureau of Labor Statistics (QCEW)
Section I – Introduction and Background
The economies of both South Carolina and the United States have improved dramatically since 
the end of the Great Recession that occurred from 2007 to 2009. In South Carolina, for example, 
the unemployment rate dropped from its peak of 11.7 percent in December 2009 to 4.3 percent 
in December 2016 while wage growth recently reached its highest level since 2011.1 One of the 
fastest growing sectors over the past decade and one that has been a major contributor to this 
current economic expansion is the life science industry. Since 2005, the annual employment 
growth rate for South Carolina’s life science industry has averaged approximately 1.7 percent, 
which is more than twice that of the state as a whole over the same time period (0.8%).
Although there is no official definition provided by the federal government, the life science industry 
can be broadly defined as encompassing firms in the fields of biotechnology, pharmaceuticals, 
biomedical technologies, biomedical devices, life systems technologies, food processing, and 
any organization that is actively engaged in the various stages of research, manufacturing, and 
distribution of products within these fields. In South Carolina, the life science industry is directly 
supported by the S.C. Biotechnology Industry Organization (SCBIO). SCBIO is a member 
organization that exists with a specific mission to support and advance South Carolina’s life 
science industry through collaboration, advocacy, workforce development, and support for 
business operations.
A strong life science industry offers a number of advantages to South Carolina. First, growth in the 
life science industry introduces a significant demand for high-wage, high-skill jobs in various STEM 
fields (science, engineering, technology, mathematics, and related occupations). 
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Second, the life science industry is contributing to the development of the state’s knowledge 
economy. The knowledge economy generally consists of industrial sectors that require innovation 
and technological development along with the commercialization of new ideas. This process – 
innovation and commercialization – is what leads to long-run economic growth and development. 
Regions with high concentrations of workers in the knowledge economy (such as the high-
tech STEM fields mentioned above) generate large volumes of human capital resources and 
knowledge spillover effects. In the United States, regions with a well-educated workforce and a 
strong innovation sector are those that are growing the fastest and have workers who are among 
the most productive, creative, innovative, and well paid in the country.2 In South Carolina, regions 
with the highest number of jobs in the knowledge economy are the regions currently experiencing 
the fastest rates of income growth – both for those working in the knowledge economy and for 
those working in the supporting service sectors.
Third, the knowledge economy is a key factor in improving a region’s rate of productivity growth. 
Regional economies have two primary ways of boosting long-run economic growth: (1) increasing 
labor force growth; and (2) increasing productivity growth. Because of current demographic 
trends in the United States, any attempt to significantly boost economic growth by increasing the 
size of the labor force will likely have minimal effects.3 This implies that the primary strategy for 
increasing long-run economic growth should be boosting productivity. This, in turn, implies that 
growth in the knowledge economy should be at the forefront of economic development efforts. 
Each of these three advantages clearly illustrate why the life science 
industry represents such a critical element to South Carolina’s 
future economic growth. The purpose of this study is to 
provide a detailed analysis of the life science industry 
in South Carolina and to estimate the industry’s current 
influence and overall statewide presence. Additionally, 
this study will conduct a review of academic research 
and private investment in the life sciences to determine 
whether any mismatch exists between the academic 
and investment priorities within the life science industry 
in South Carolina and general industry demand. Finally, 
this study will report the results of a series of firm-level 
interviews of life science companies in South Carolina 
to provide perspective on the perceived strengths and 
weaknesses of the life science industry from local 
firms operating from within it.
2 For a full discussion on the benefits of knowledge economies in the United States, see Moretti, E., (2012).
  The New Geography of Jobs. New York: Houghton Mifflin Harcourt.
3 These demographic trends include, among other things, the aging and retiring of the baby boomer generation.
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SC Commerce was able to obtain the most recent listing of all companies in South Carolina from 
Hoover’s and to perform this match for all life science NAICS codes.4 The matched dataset was 
then manually inspected to ensure accuracy and the resulting firm list is what will be denoted for 
the remainder of this report as constituting the life science industry in South Carolina. 
These 25 NAICS codes are 
aggregated into the following 
major industry categories:
• Agricultural Products
• Drugs and Pharmaceuticals
• Medical Devices and Equipment
• Research, Testing, and Medical  
   Laboratories
• Bioscience-Related Distribution
4 All firm-level data obtained through SC Commerce are current as of February 2017.
The process of matching these 25 NAICS codes 
to individual firms is accomplished through the 
use of the Hoover’s database. Hoover’s Inc. is a 
subsidiary of Dun and Bradstreet and is based out 
of Austin, Texas. The Hoover’s database is one 
of the largest commercial databases available, 
containing firm-level information on over 85 million 
companies across more than 1,000 industry 
segments. Among the variables that the Hoover’s 
database tracks for each firm is the six-digit NAICS 
code. Thus, firms that are categorized within the life 
science industry can be successfully identified by 
matching the appropriate life science NAICS codes 
to the Hoover’s list of South Carolina firms. 
Section II – The Economic Impact of the Life Science   
        Industry in South Carolina
Defining the Life Science Industry
In order to formalize the broad definition of the life science industry outlined above, SCBIO and the 
South Carolina Department of Commerce (SC Commerce) jointly identified the 25 NAICS (North 
American Industrial Classification System) codes into which South Carolina’s life science firms are 
primarily concentrated. Since each firm in South Carolina is tied to a specific six-digit NAICS code, 
it is possible to identify all of the firms that are associated with this NAICS code list.
As of February 2017, the life science industry in South Carolina 
contains approximately 15,012 employees across 402 firms. Note 
that the majority of the industry falls within the categories of Medical 
Devices & Equipment and Bioscience-Related Distribution. 
4 All firm-level data obtained through SC Commerce are current as of February 2017.
A summary of the life science industry appears below in Table 1.
Table 1 – The Life Science Industry in South Carolina
AGRICULTURAL PRODUCTS
NAICS
311221
311222
311223
325193
325221
325311
325312
325314
325320
NAICS
325411
325412
325413
325414
NAICS
541380*
54171*
621511
NAICS
423450
424210*
424910*
NAICS
334510
334516
334517
339112
339113
339114
#of Firms
2
0
0
1
0
4
0
1
7
#of Firms
4
38
0
6
#of Firms
23
31
63
#of Firms
90
26
46
402
#of Firms
13
6
2
14
24
1
Total Employment
97
0
0
15
0
40
0
6
424
Total Employment
125
2,102
0
54
Total Employment
551
559
1,865
Total Employment
2,477
557
2,541
15,012
Total Employment
300
60
210
931
2,090
8
Description
Wet Corn Milling
Soybean Processing
Other Oilseed Processing
Ethyl Alcohol Manufacturing
Cellulosic Organic Fiber Manufacturing
Nitrogenous Fertilizer Manufacturing
Phosphatic Fertilizer Manufacturing 
Fertilizer (Mixing Only) Manufacturing
Pesticide and Other Agricultural Chemical Manufacturing
Description
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic)  Manufacturing
Description
Testing Laboratories
R&D in the Physical, Engineering, and Life Sciences
Medical Laboratories
Description
Medical, Dental, & Hospital Equp. and Supplies Merchant Whslrs.
Drugs and Druggists’ Sundries Merchant Wholesalers
Farm Supplies Merchant Wholesalers
Totals
Description
Electromedical and Electrotherapeutic Apparatus Manufacturing
Analytical Laboratory Instrument Manufacturing
Irradiation Apparatus Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
DRUGS AND PHARMACEUTICALS
MEDICAL DEVICES AND EQUIPMENT
RESEARCH, TESTING, AND MEDICAL LABORATORIES
BIOSCIENCE-RELATED DISTRIBUTION
*includes only the portions of industries engaged in relevant life science activities
Economic Impact Methodology
Although the total volume of economic activity as measured in Table 1 is significant, it does 
not provide a complete picture of the impact of the life science industry on South Carolina’s 
economy. The expenditures that occur as part of the ongoing operations of these 402 firms 
represent direct economic activity of life sciences within South Carolina. However, these 
expenditures also lead to additional job creation and economic activity throughout the state by 
way of the economic multiplier effect (or economic ripple effect).
Economic multiplier effects can be divided into direct, indirect, and induced impacts. The 
direct effect represents all in-state purchases made by firms operating within the life science 
industry. These may include, for example, employee wages and benefits, construction 
materials purchased, computer equipment, or other overhead and administrative costs. This 
spending increases demand for goods and services and leads to the creation of new jobs and 
more income for employees and suppliers of firms within the life science industry.
The indirect effect reflects all of the additional economic impacts resulting from inter-
industry linkages between other local businesses in South Carolina. For example, a medical 
equipment manufacturer may need to purchase various plastic components as raw inputs 
for the medical equipment being manufactured and assembled. In this situation, in-state 
plastic manufacturers may see an increase in demand, which would require them to purchase 
additional supplies from their own vendors and to potentially hire additional employees if the 
increase in demand were large enough. The vendors of the plastic manufacturers would then 
see an increase in demand and have to purchase additional inputs as well, and so on. These 
indirect effects would thus ripple throughout the state’s economy.
The induced effect reflects additional economic activity that results from increases in the 
spending of household income. For example, when the aforementioned medical equipment 
manufacturer enters the South Carolina market, it hires employees who earn an income. These 
employees then spend part of their income locally on, for example, food, entertainment, or 
housing. These industries will then see an increase in demand for their goods and services, 
which will lead to higher incomes for some of their employees, part of which will also be 
spent locally.
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These successive rounds of indirect and induced spending do not go on forever, which is why 
we can calculate a value for each of them. In each round, money is “leaked out” for a variety 
of reasons. For example, firms may purchase some of their supplies from vendors located 
outside of the local area. In addition, employees will save part of their income or spend part 
of it with firms located outside of South Carolina. In order to determine the total economic 
impact that will result from an initial direct impact, economic multipliers are used. An economic 
multiplier can be used to determine the total impact (direct, indirect, and induced) that results 
from an initial change in economic activity (the direct impact). Multipliers are different in each 
sector of the economy and are largely determined by the size of the local supplier network as 
well as the particular region being examined. In addition, economic multipliers are available to 
calculate not just the total impact, but also the total employment and income levels associated 
with the total impact.
To estimate the economic impacts in this study, a detailed structural model (known as an 
input-output model) of South Carolina that contains specific information on economic linkages 
between all industries within the state was used. This study utilized the input-output modeling 
software IMPLAN to calculate all estimates.
Primary Results
The structural input-output model estimates economic impacts in terms of three specific 
measures that will be used in this report: economic output, employment, and labor income. 
Economic output is simply defined as the dollar value of the final goods and services 
purchased that can be attributed (directly or indirectly) to all business activity within the 
life science industry. It can also be thought of as an aggregate measure of total spending 
resulting from an initial direct expenditure. Because it includes all spending by consumers 
and businesses on both goods and services, it is an all-inclusive measure of the impact on 
total economic activity. Employment measures the impact on jobs in terms of the total number 
of FTE positions.5 Labor income represents total employee compensation, including wages, 
salaries, and benefits.
5 FTE refers to full-time equivalent positions. 
Note first that the direct impact of 15,012 employees is estimated to directly support 
approximately $7.3 billion in economic activity across South Carolina. In other words, the 402 
firms identified as representing the life science industry generates approximately $7.3 billion 
worth of economic output every year.  
This $7.3 billion also leads to an additional $2.6 billion in indirect effects, which is the estimated 
total dollar value of the increased demand for goods and services of local suppliers that result 
from the $7.3 billion in direct procurement activity among the 402 life science companies. This 
direct output also leads to another $1.6 billion in induced effects, which represents the total 
increase in household spending that occurs across a variety of industries in South Carolina. 
The combination of the direct, indirect, and induced impacts leads to a total impact of $11.4 
billion on the state of South Carolina that is associated with the life science industry. 
Table 2 also details the indirect and induced impacts for labor income and employment. The 
$2.6 billion in indirect effects is associated with 16,160 additional employees working to fill 
the increased demand for industry related local suppliers. This indirect employment is also 
associated with nearly $875 million in additional labor income. Another 12,295 employees are 
supported through the nearly $1.6 billion estimated induced impact. These are employees 
who work in industries that experience an increase in demand due to increased household 
spending. For example, if an overhead-related purchase for a life science firm led to an 
increase in demand for a particular supplier, this would lead to additional income for some 
of the supplier’s employees. Additional spending on the part of the supplier’s employees 
that results from their increased income reflects the induced impact. This spending leads to 
increased demand in a variety of industries that ultimately supports these 12,295 jobs, $1.6 
billion in economic output, and $477 million in labor income.
As described above, there are currently 402 firms in South Carolina’s life science industry that 
employ approximately 15,012 employees across the state. This represents the direct impact of 
the industry, which then leads to indirect and induced impacts through increases in demand 
for goods and services in other related local industries and through increases in household 
spending activity – all of which are estimated using economic multipliers. Each impact is 
reported in Table 2, along with the accompanying totals. These totals represent the overall 
impact of the life science industry on the state of South Carolina.
Direct Impact
Table 2 - Economic Impact of the Life Science Industry in South Carolina
Induced Impact
Indirect Impact
Total Impact 43,467
12,295
16,160
Employment
15,012
$2,532,074,137
$476,643,505
$874,621,999
Labor Income
$1,180,809,633
$11,446,580,195
$1,587,869,009
$2,557,715,922
Economic Output
$7,300,995,264
Employment Growth: Quantity vs. Quality
The primary means by which economists measure the health of a local region (or state) is 
through its rate of employment growth and income growth. Simply put, a regional economy 
does well when it is producing new jobs and generating wage gains for existing jobs at a 
relatively rapid pace. Thus, both job quantity and job quality matter if the goal is to produce 
healthy, long-run economic growth.
In South Carolina, the life science industry is contributing both to employment quality and to 
employment quantity. For example, the economic impact results detailed in Table 2 reveals a 
high employment multiplier effect that is documented in Figure 1. 
Employment Multiplier: 2.9
Direct Effect5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
45,000
12,295
Jobs
16,160
Jobs
15,012
Jobs
A total of 43,467 jobs are supported in South Carolina’s economy as a 
result of the direct economic activity associated with the life science 
industry. In other words, the 15,012 jobs in the life science industry give 
rise to an additional 28,455 jobs in South Carolina. The employment 
multiplier for South Carolina’s life science industry is therefore 2.9 – 
implying that for every 10 jobs created by the life science industry in South 
Carolina, an additional 19 jobs are created elsewhere in the state. 
Figure 1
The Employment 
Multiplier Effect of 
the S.C. Life Science 
Industry
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“...the	life	science	industry	has	the	ability	to	scale	up	employment	in	
South	Carolina	in	a	way	that	few	other	industries	possess.”
The importance of this multiplier effect cannot be overstated. To put this into perspective, the 
average employment multiplier across all industries in South Carolina is 1.9, with very few 
industries having an employment multiplier above 2.5.6 Thus, the life science industry has the 
ability to scale up employment in South Carolina in a way that few other industries possess. 
This represents a key finding of this study. Investments in the life sciences have the potential 
to generate significant employment growth for the Palmetto State in the coming years.
The life science industry also contributes to high employment quality – as measured by wage 
levels. The estimates in Table 2 provide both the number of jobs and the total labor income 
associated with those jobs, which allows for the estimation of the average wage associated 
with each. Figure 2 details these estimates.
Figure 2 - S.C. Annual Labor Income Comparisons
$10,000$ $20,000 $30,000 $40,000 $50,000 $60,000 $70,000 $80,000
$78,658
$47,488
$40,293
Avg. Wage Among All Jobs Supported
Directly through the Life Science Industry
Avg. Wage Among All Jobs Supported
through the Multiplier Effect
Avg. Wage Among All Jobs
In South Carolina
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6 Source: IMPLAN modeling software; South Carolina estimates for calendar year 2015.
As of 2017, the average job within the life science industry in South Carolina is estimated to 
pay approximately $78,658 annually. This is nearly double that of the average job in South 
Carolina. Among all 28,455 jobs associated with the multiplier effect, the average annual wage 
is approximately $47,488.
“The	average	job	in	the	life	science	industry	pays	nearly	twice	that	of	
the	average	job	in	South	Carolina.”
Another way to compare these wage estimates is to examine how the average wage across 
all 43,467 jobs supported by the life science industry (either directly or indirectly) compares 
to the average wage across all jobs supported (either directly or indirectly) by other leading 
industries in South Carolina. Figure 3 explicitly compares the average wage across all life 
science-related jobs (including those due to the multiplier effect) with those supported 
through the aerospace, automotive, and tire clusters. 
Figure 3 – Average Wage Among All Jobs Supported by Select S.C. Industries
Note: Averages include multipler eects
$0
$10,000
$20,000
$30,000
$40,000
$50,000
$60,000
$70,000
$80,000
$40,293
$58,253
$64,120
$70,008
$58,981
Avg. Wage 
Among All Jobs 
in South 
Carolina
Avg. Wage 
Among All Jobs 
Supported 
through 
Life Science 
Industry
Avg. Wage 
Among All Jobs 
Supported 
through 
Automotive 
Industry
Avg. Wage 
Among All Jobs 
Supported 
through 
Aerospace 
Industry
Avg. Wage 
Among All 
Jobs 
Supported 
through 
Tire Industry
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6 Source: IMPLAN modeling software; South Carolina estimates for calendar year 2015.
Among the many factors that influence the long-run growth prospects of the life science 
industry in South Carolina is the extent to which federal research dollars entering the state to 
support academic research in the life sciences help to grow the size and scope of the industry 
over time. Specifically, if academic research funding is appropriately matched to industry 
demand, one may expect to see a process in which federal funding leads to various research 
activities that generate new patents that, in turn, eventually translate into new business activity. 
This process of market driven innovation is summarized in Figure 4.
If a breakdown in this process occurs, it will likely be due to one of two causes: (1) the out-
of-state research funding does not result in any new patent activity; (2) the new patents do 
not represent innovations that have significant market demand in South Carolina. In order 
to assess whether there is any breakdown in this process in South Carolina – that is, an 
academic research/business mismatch – data were collected from the following sources to 
examine each of the three components outlined in Figure 4:
- Out-of-State Research Funding7 
 o National Science Foundation (NSF) Research Grants Awarded in South Carolina
 o National Institutes of Health (NIH) Research Grants Awarded in South Carolina
 o South Carolina Venture Capital Investments
- South Carolina Patent Activity8 
 o Total patents issued in South Carolina
- Growth in Industry Demand9
 o Total South Carolina employment within the life science industry
 o Total number of South Carolina firms within the life science industry
Figure 2 - S.C. Annual Labor Income Compariso s
$10,000$ $20,000 $30,000 $40,000 $50,000 $60,000 $70,000 $80,000
$78,658
$47,488
$40,293
Avg. Wage Among All Jobs Supported
through the Multiplier Effect
Avg. Wage Among All Jobs Supported
through the Multiplier Effect
Avg. Wage Among All Jobs
In South Carolina
Out-of-State Research Funding
Higher Growth in Number of New Patents
Growth in Industry Demand
Measured through dollar volume of NSF Funding, NIH Funding, Venture Capital Investment
Measured through growth in total employment and total number of firms
Figure 4 - The Process of Market Driven Innovation
Section III – Assessing any Academic Research/Business 
Mismatch in South Carolina’s Life Science Industry
7 Sources: NSF Higher Education Research and Development Survey (2015); NIH Awards by Location and Organization (2015); 
  Thomson Reuters Venture Capital Database (2011-2015).
8 Source: U.S. Patent and Trademark Office (2011-2015). 
9 Source: Hoover’s Database (February 2017).
The process of market driven innovation outlined in Figure 4 was examined for the major 
industry categories within the life science industry. These results are summarized in 
Tables 3-4 and discussed below.
Summary: Venture Capital Investment and Industry Demand
The innovation sector within South Carolina’s life science industry consists of approximately 
7,021 employees across 154 firms, as Table 3 denotes. Specifically, this subset of the life 
science industry excludes all industry NAICS codes previously identified in Table 1 that are not 
representative of innovation activities. Thus, all categories within Bioscience-Related Distribution 
were excluded as well as Testing Laboratories (NAICS code 541380) and Medical Laboratories 
(NAICS code 621511).
Note in Table 3 that all venture capital investment in South Carolina within the life science industry 
occurred within the Drugs, Pharmaceuticals, Medical Devices, and Equipment categories, which 
totaled $112.5 million between 2011 and 2015. Additionally, the primary concentration of firms 
and total employment within the life science innovation sectors are also within this same set of 
categories (70.1% and 83.7%, respectively). Thus, life science-related venture capital investment 
in South Carolina appears to be supporting the successful life science innovation sectors.
7 Sources: NSF Higher Education Research and Development Survey (2015); NIH Awards by Location and Organization (2015); 
  Thomson Reuters Venture Capital Database (2011-2015).
8 Source: U.S. Patent and Trademark Office (2011-2015). 
9 Source: Hoover’s Database (February 2017).
Agricultural Products
Total Activity in Innovation Sectors
Table 3 - Percentage of Total Activity within the Life Science Industry by Major Category
Research, Testing,
and Medical Labs
Drugs, Pharmaceuticals,
Medical Devices, and Equipment
---------------------------------------- -------------------
0.0%
$112.5M
100.0%
Venture Capital
Investment
0.0%
154
---------
20.1%
70.1%
Firms Employment
9.8%
7,021
--------------------
8.0%
83.7%
8.3%
Summary: Patents and Research Funding
Table 4 summarizes the number of patents issued in South Carolina for life science-related 
activities as well as the total dollar volume of NSF/NIH research funding directed towards life-
science related grants. Both of these elements are critically important to the long-run health 
of the life science industry in South Carolina because they represent the building blocks for 
its growth. Put simply, ongoing research and new patent activity are measures of the current 
status of life science-related activities in the pipeline that will contribute to the future growth of 
the industry. Note that in Table 4, both indicators have shown a postive overall rate of growth 
since 2012.10
2013
Table 4 – Growth in S.C. Patent and Research Funding Activity: 2012-2015
2015
2014
Avg. Annual Growth Rate 
2012-2015 +2.4%
193 (+5.5% YR/YR)
183 (-9.4% YR/YR)
Patents Issued
202 (+12.2% YR/YR)
NSF/NIH Research Funding
+1.6%
$521.5M (+1.4% YR/YR)
$514.4M (+2.7% YR/YR)
$500.7M (+0.3% YR/YR)
10 There is typically a significant lag (of between six and nine years) between the point at which research grant funding is approved 
   for a project and the point at which a patent based on this research project is issued. More information on average time lags 
   can be found at the U.S. Patent and Trademark Office.
11 Appendix II provides a detailed breakout of this patent activity
11
Thus far, this report has examined the current size and scope of the life science industry in 
South Carolina, including the extent to which the process of market driven innovation helps to 
generate high levels of economic activity within the industry. In order to establish appropriate 
priorities to grow the industry in the future, however, it is important to examine the strengths 
and weaknesses of the state’s life science industry from a firm-level viewpoint. By gaining an 
understanding of what firms themselves perceive as the major strengths and weaknesses of 
the industry, SCBIO and other policymakers will be better able to facilitate positive economic 
development efforts.
In order to assess the opinions of firms within South Carolina’s life science industry, a series 
of 25 interviews were conducted with firms in the life science industry across South Carolina.12 
Although the markets and geographic regions served by these firms were diverse, the sample 
consisted of primarily larger organizations. The average annual sales volume for interviewed 
firms was $34.9 million with an average employment count of 183. Based upon the information 
obtained from these interviews, this section summarizes and provides three key findings from 
the interview responses.
Key Finding 1: Firms Generally Expect a Sizable Increase in Market Demand in the 
Coming Years
When asked about future market trends – and specifically how the market demand for their 
products/services will likely change – 67 percent reported an expectation of significant growth 
for their companies in excess of 10 percent per year for the next five years. The remaining 
respondents also reported an expectation of positive growth, but by less than 10 percent 
per year. Most cited the aging population and the accompanying overall steady increase in 
demand for healthcare as the primary reason for this expectation of growth.
An additional factor contributing to this high demand is the growing overlap between 
advanced manufacturing and the life sciences. For example, multiple firms stated that the 
market for medical devices is moving towards the creation of devices specifically to aid and 
support minimally invasive medical procedures. These same types of devices, however, are 
also in demand in the aerospace, energy, and automotive industries to aid in 
precision manufacturing.
Section IV  – A Firm-Level Perspective on the Strengths 
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12 All interviews were conducted by SCBIO personnel. The survey instrument used appears in Appendix I.
Key Finding 2: Workforce Shortages and Limitations
Firms consistently stated their need for a greater supply of high-skilled workers, especially in 
the smaller metropolitan regions of South Carolina (e.g., Florence, Sumter). Part of this need 
stems from the fact that the life science industry in South Carolina is relatively small, which 
results in a high inflow/outflow of workers to and from the state. For example, one employer 
stated that when a life science-related company closes, the high-skilled workers often have 
to leave South Carolina because the industry is not large enough for them to find additional 
employment within their profession locally. This, in turn, makes it harder for any new firm that 
later wants to locate in South Carolina to find the workforce that it needs. The Raleigh, NC and 
Atlanta, GA markets were both cited as major competitors for the state’s workforce.
Key Finding 3: South Carolina is Perceived as Having a Positive Business Climate
Firms were asked to state the major advantages and disadvantages of being located in South 
Carolina. The following represents the major responses given:
Perceived Advantages
- High Quality Workforce
- High Quality of Life
- Low Cost of Living
- Right to Work State
- Close Proximity to the Port of Charleston
- Technical College System that Supports Manufacturing
Perceived Disadvantages
- A need for additional medical device manufacturers in the life science supply chain
- Access to major airports
- Difficulty in recruiting top-level talent from outside of the state
- R&D is limited in life sciences at South Carolina universities
- Perceived quality of K-12 education negatively impacts out-of-state workforce recruitment
Despite the listed disadvantages, when asked about alternative states or regions that provide 
a better business climate for the life science industry, only three respondents indicated 
locations perceived to be superior to South Carolina. These states were Florida, North 
Carolina, and New Jersey. The primary reason listed for each state was the fact that each has 
a larger, more developed life science cluster with many of the advantages that this brings 
(e.g., a more developed supply chain, a larger workforce pool, etc.). 
To summarize, the responses from the interview process revealed a generally positive 
impression of the state of South Carolina’s business climate as well as anticipated positive 
increases in future demand and an increase in the interaction with other manufacturing 
markets. The major limiting factor identified for the state was the high-skilled workforce 
shortage. This represents a significant opportunity for South Carolina; effectively addressing 
this workforce shortage would not only increase the state’s overall competitiveness, but also 
allow South Carolina to fully capitalize on its existing advantages.  
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The life science industry has been a major contributor to South Carolina’s economy over the 
past decade. Since 2005, for example, employment growth has averaged approximately 1.7 
percent per year, which is more than twice that of the state as a whole over the same time 
period. A strong life science industry is important to the Palmetto State for many reasons. First, 
growth in the life science industry supports demand for high-wage, high-skill positions across 
various STEM fields. Second, growth in the life science industry supports the development of 
the knowledge economy. Regions across the U.S. with a strong knowledge economy typically 
have the highest rates of economic growth as well as the highest rates of income growth for 
their residents. Third, the knowledge economy represents a key factor in boosting a region’s 
rate of productivity growth, which is critical for long-run economic development.
This study has found that South Carolina’s life science industry currently consists of 
approximately 15,012 employees across 402 firms, which supports a total annual economic 
impact of approximately $11.4 billion in total economic output. This dollar volume of 
activity is associated with 43,467 total jobs and over $2.5 billion in labor income for South 
Carolinians. Additionally, the average direct job in the life science industry pays an annual 
total compensation of $78,658, which is about 95 percent higher than the average annual 
compensation in South Carolina ($40,293).
The total economic impact of the life science industry is also associated with an employment 
multiplier of 2.9. In other words, for every 10 jobs that are created within the life science industry 
in South Carolina, an additional 19 jobs are created elsewhere in the state due to the effects of 
the employment multiplier. This multiplier effect is one of the highest in South Carolina, meaning 
that the life science industry has a relatively unique ability to scale up employment.
This study also conducted a review of academic research and private investment in South 
Carolina’s life science industry. This review was then used to determine if any mismatch exists 
between the academic and investment priorities within the life sciences and general industry
demand. The process of market driven innovation whereby research and investment dollars 
drive patent activity, which then drives additional employment and firm growth, has been found 
to be largely successful.
Finally, this study provided the results of a series of firm-level interviews of life science 
companies in South Carolina assessing perceived strengths and weaknesses of the life science 
industry. The primary results of these interviews indicate that while firms anticipate high market 
demand and have a favorable view of the overall business climate in South Carolina, they also 
consistently note that there is a shortage of high-skilled workers in the state. Addressing this 
need has the potential to improve the state’s overall competitiveness and to enhance the long-
run growth potential of the life science industry.  
Section V  – Conclusion
Part I: Company Overview
Thank you for agreeing to participate in the SCBIO Life Sciences Industry Survey! 
Please begin by providing the following information regarding your company’s facility:
- Company Name
- Physical Address
- City
- Zip Code
- Phone
Part II-A: Company Production Profile
What are the products produced or services offered at this facility? Please list primary 
products/services first.
Please estimate the average annual sales volume at this facility:
(a) Less than $1 million
(b) $1 million to $5 million
(c) $5 million to $10 million
(d) $10 million to $50 million
(e) Greater than $50 million
Please estimate the average annual total employment at this facility:
(a) Less than 10 employees
(b) 10 to 50 employees
(c) 50 to 100 employees
(d) 100 to 500 employees
(e) More than 500 employees
What market(s) does this facility serve (e.g., medical, consumer goods, wholesale, retail, etc.)? 
Please be specific.
Part II-B: Business Operations
For each of the following Business Operations listed, please estimate the NUMBER OF 
EMPLOYEES at this facility working in each category
- Number of Production/Manufacturing Employees
- Number of Research and Development/Administration Employees
Appendix I – S.C. Life Sciences Industry Survey
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Part III: Future Challenges and Opportunities
How do you anticipate that the market demand for your goods/services will change within the 
next five years? Please select one:
(a) Increase by more than 10% per year
(b) Increase by less than 10% per year
(c) Stay the Same
(d) Decrease by less than 10% per year
(e) Decrease by more than 10% per year
What market trends are you currently observing that lead you to your answer?
Do you expect to INCREASE, DECREASE, or MAINTAIN your current market share over the 
next five years? (Increase/Decrease/Maintain)
Over the next five years, I expect employment at this facility to…
(a) Increase by more than 10% per year
(b) Increase by less than 10% per year
(c) Stay the Same
(d) Decrease by less than 10% per year
(e) Decrease by more than 10% per year
Over the next five years, I expect production at this facility to…
(a) Increase by more than 10% per year
(b) Increase by less than 10% per year
(c) Stay the Same
(d) Decrease by less than 10% per year
(e) Decrease by more than 10% per year
What do you view as the primary obstacles to achieving your corporate goals? These can 
be related to any of the following: market growth, hiring or workforce development, access 
to working capital, access to research partnerships, locating suppliers, locating customers, 
production costs/flexibility/quality
Please provide three specific examples of actions that you would like to see taken by SCBIO 
or the state of South Carolina that would best help your business over the next five years.
Please describe what you see as the top 3 advantages and the top 3 disadvantages of being 
located in South Carolina.
Are there other states/regions that you believe provide a better business climate for the life 
sciences industry and your facility in particular than South Carolina? If so, which states/regions 
and why? Please be specific.
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Appendix II – S.C. Patents in the Life Sciences Issued 
between 2011 and 2015
Description Number of 
Patents Issued
Associated 
NAICS Code
Food or Edible Material: Processes, Compositions, and Products 13 3112
Fuel and Related Compositions 4 3251
Gas Separation: Processes 12 3251
Chemistry of Inorganic Compounds 16 3251
Catalyst, Solid Sorbent, or Support Therefor: Product or Process of Making 6 3251
Chemistry: FischerTropsch Processes; or Purification or Recovery of Products Thereof 1 3251
Chemistry of Hydrocarbon Compounds 2 3251
Boots, Shoes, and Leggings 4 3252
Solid AntiFriction Devices, Materials Therefor, Lubricant or Separant Compositions for Moving 
Solid Surfaces, and Miscellaneous Mineral Oil Compositions
2 3252
Synthetic Resins or Natural Rubbers (includes Classes 520528) 70 3252
Receptacles 30 3254
Drug, BioAffecting and Body Treating Compositions (includes Class 514) 137 3254
Chemistry: Molecular Biology and Microbiology 66 3254
Chemistry: Natural Resins or Derivatives; Peptides or Proteins; 
Lignins or Reaction Products Thereof
3 3254
Organic Compounds (includes Classes 532570) 26 3254
Geometrical Instruments 16 3345
Measuring and Testing 63 3345
Woodworking 2 3345
Automatic Temperature and Humidity Regulation 1 3345
Radiant Energy 25 3345
Electricity: Measuring and Testing 44 3345
Communications: Directive Radio Wave Systems and Devices (e.g., Radar, Radio Navigation) 1 3345
Optics: Measuring and Testing 23 3345
Horology: Time Measuring Systems or Devices 2 3345
XRay or Gamma Ray Systems or Devices 2 3345
Optical Waveguides 56 3345
Chemical Apparatus and Process Disinfecting, Deodorizing, Preserving, or Sterilizing 21 3345
Chemistry: Analytical and Immunological Testing 14 3345
Surgery: Light, Thermal, and Electrical Application 3 3345
DP: Vehicles, Navigation, and Relative Location (Data Processing) 41 3345
DP: Measuring, Calibrating, or Testing (Data Processing) 26 3345
Surgery (includes Class 600) 29 3391
ElongatedMemberDriving Apparatus 3 3391
Thermal Measuring and Testing 6 3391
Dentistry 5 3391
Abrading 10 3391
Surgery: Kinesitherapy 1 3391
Surgery: Splint, Brace, or Bandage 5 3391
Surgery (Medicators and Receptors) 51 3391
Surgery (instruments) 32 3391
Prosthesis (i.e., Artificial Body Members), Parts Thereof, or Aids and Accessories Therefor 25 3391
Totals 899 N/A
